Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT1- and epidermal growth factor-receptor function.

European Journal of Heart Failure
Ying XuHendrik Buikema

Abstract

We previously showed that enhanced myogenic constriction (MC) of peripheral resistance arteries involves active AT(1) receptors in chronic heart failure (CHF). Recent data suggest both transactivation of EGF receptors and caveolae-like microdomains to be implicated in the activity of AT(1) receptors. Thus, we assessed their roles in increased MC in mesenteric arteries of CHF rats. Male Wistar rats underwent myocardial infarction to induce CHF and were sacrificed after 12 weeks. The number of caveolae in smooth muscle cells (SMC) of mesenteric arteries of CHF rats was decreased by 43.6 +/- 4.0%, this was accompanied by increased MC, which was fully normalized to the level of sham by antagonists of the AT(1)-receptor (losartan) or EGF-receptor (AG1478). Acute disruption of caveolae in sham rats affected caveolae numbers and MC to a similar extent as CHF, however MC was only reversed by the antagonist of the EGF-receptor, but not by the AT(1)-receptor antagonist. Further, in sham rats, MC was increased by a sub-threshold concentration of angiotensin II and reversed by both AT(1)- as well as EGF-receptor inhibition. In contrast, increased MC by a sub-threshold concentration of EGF was only reversed by EGF receptor inhibition. These...Continue Reading

References

Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·E J SmartR G Anderson
Nov 1, 1994·Cardiovascular Research·Y Sun, K T Weber
Apr 30, 1999·Physiological Reviews·M J Davis, M A Hill
Aug 19, 1999·The New England Journal of Medicine·R W Schrier, W T Abraham
Apr 4, 2000·Journal of Cardiac Failure·R YoshimuraK Sunagawa
Feb 13, 2001·Molecular Pharmacology·Z GáborikL Hunyady
May 16, 2001·Current Opinion in Lipidology·C J Fielding
May 18, 2001·American Journal of Physiology. Heart and Circulatory Physiology·L H YoungA M Lefer
Aug 13, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Karl DrejaKarl Swärd
Oct 28, 2005·Current Medicinal Chemistry. Cardiovascular and Hematological Agents·Hiroyuki SuzukiSatoru Eguchi
Feb 4, 2006·The Journal of Investigative Dermatology·Sylviane LambertRobert Gniadecki
Mar 28, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Cherry Ballard-CroftRobert D Lasley
Jul 15, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Haruhiko OhtsuSatoru Eguchi

❮ Previous
Next ❯

Citations

Jan 18, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Elaine WanSteven O Marx
Jun 9, 2012·The International Journal of Biochemistry & Cell Biology·Michael A Hill, Gerald A Meininger
Mar 12, 2011·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Peter VavrinecRobert H Henning
Jul 14, 2012·American Journal of Physiology. Renal Physiology·Peter VavrinecRichard P E van Dokkum
Oct 12, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Youhua WangWeijin Zang
Jan 23, 2009·Current Opinion in Pharmacology·Richard Pe van Dokkum, Hendrik Buikema

❮ Previous
Next ❯

Related Concepts

Related Feeds

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.